Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.12 USD
−30.05 M USD
29.43 M USD
15.98 M
About TriSalus Life Sciences, Inc.
Sector
Industry
CEO
Mary T. Szela
Website
Headquarters
Westminster
Founded
2020
FIGI
BBG00Z1TKRG8
TriSalus Life Sciences, Inc. is an oncology company, which engages in the business of integrating standard-of-care treatments and investigational immunotherapeutic with disruptive pressure enabled drug delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. The company was founded on September 11, 2020, and is headquartered in Westminster, CO.
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of TLSI is 5.56 USD — it has increased by 3.93% in the past 24 hours. Watch TriSalus Life Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange TriSalus Life Sciences, Inc. stocks are traded under the ticker TLSI.
TLSI stock has risen by 6.72% compared to the previous week, the month change is a −2.97% fall, over the last year TriSalus Life Sciences, Inc. has showed a −41.48% decrease.
We've gathered analysts' opinions on TriSalus Life Sciences, Inc. future price: according to them, TLSI price has a max estimate of 16.00 USD and a min estimate of 9.00 USD. Watch TLSI chart and read a more detailed TriSalus Life Sciences, Inc. stock forecast: see what analysts think of TriSalus Life Sciences, Inc. and suggest that you do with its stocks.
TLSI reached its all-time high on Aug 11, 2023 with the price of 16.24 USD, and its all-time low was 3.32 USD and was reached on Nov 21, 2023. View more price dynamics on TLSI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
TLSI stock is 7.84% volatile and has beta coefficient of 0.34. Track TriSalus Life Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is TriSalus Life Sciences, Inc. there?
Today TriSalus Life Sciences, Inc. has the market capitalization of 210.38 M, it has decreased by −2.50% over the last week.
Yes, you can track TriSalus Life Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
TriSalus Life Sciences, Inc. is going to release the next earnings report on Aug 14, 2025. Keep track of upcoming events with our Earnings Calendar.
TLSI earnings for the last quarter are −0.39 USD per share, whereas the estimation was −0.22 USD resulting in a −77.56% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about TriSalus Life Sciences, Inc. earnings.
TriSalus Life Sciences, Inc. revenue for the last quarter amounts to 9.17 M USD, despite the estimated figure of 9.04 M USD. In the next quarter, revenue is expected to reach 10.69 M USD.
TLSI net income for the last quarter is −10.38 M USD, while the quarter before that showed −10.11 M USD of net income which accounts for −2.64% change. Track more TriSalus Life Sciences, Inc. financial stats to get the full picture.
No, TLSI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 26, 2025, the company has 110 employees. See our rating of the largest employees — is TriSalus Life Sciences, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TriSalus Life Sciences, Inc. EBITDA is −30.73 M USD, and current EBITDA margin is −119.46%. See more stats in TriSalus Life Sciences, Inc. financial statements.
Like other stocks, TLSI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TriSalus Life Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TriSalus Life Sciences, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TriSalus Life Sciences, Inc. stock shows the sell signal. See more of TriSalus Life Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.